Ingrid E. Lundberg

Ingrid E. Lundberg

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 261 publications

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

Journal: The New England journal of medicine

Published: May 13, 2026

Correction to: Cardiac involvement in newly diagnosed patients with idiopathic inflammatory myopathies is associated with skeletal muscle involvement.

Correction to: Cardiac involvement in newly diagnosed patients with idiopathic inflammatory myopathies is associated with skeletal muscle involvement.

Journal: Clinical and experimental rheumatology

Published: May 07, 2026

Identification of Novel Risk Loci for Common B-Cell Lymphoma Subtypes Through Cross-Trait Analysis with Idiopathic Inflammatory Myopathies.

Identification of Novel Risk Loci for Common B-Cell Lymphoma Subtypes Through Cross-Trait Analysis with Idiopathic Inflammatory Myopathies.

Journal: Cancers

Published: March 24, 2026

Elevated sST2 associates with cardiac involvement and declines after treatment in newly diagnosed patients with idiopathic inflammatory myopathies.

Elevated sST2 associates with cardiac involvement and declines after treatment in newly diagnosed patients with idiopathic inflammatory myopathies.

Journal: Arthritis research & therapy

Published: March 11, 2026

Plasma proteome reflects tissue damage and clinical manifestations in patients with inflammatory myopathies.

Plasma proteome reflects tissue damage and clinical manifestations in patients with inflammatory myopathies.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 07, 2026

Pregnancy outcomes in women with idiopathic inflammatory myopathies: a single-centre study from Sweden.

Pregnancy outcomes in women with idiopathic inflammatory myopathies: a single-centre study from Sweden.

Journal: Scandinavian journal of rheumatology

Published: January 23, 2026

Pan-disease blood protein profiles of rheumatic autoimmune diseases.

Pan-disease blood protein profiles of rheumatic autoimmune diseases.

Journal: Communications medicine

Published: December 12, 2025

Risk of second primary cancer and death in patients with idiopathic inflammatory myopathies.

Risk of second primary cancer and death in patients with idiopathic inflammatory myopathies.

Journal: Seminars in arthritis and rheumatism

Published: November 24, 2025

Anti-MDA5 monoclonal antibodies from patients with dermatomyositis - B cell characteristics and differential targeting of the helicase domains.

Anti-MDA5 monoclonal antibodies from patients with dermatomyositis - B cell characteristics and differential targeting of the helicase domains.

Journal: Journal of autoimmunity

Published: November 20, 2025

Inhibition of the type I interferon receptor pathway protects against muscle weakness induced by dermatomyositis serum.

Inhibition of the type I interferon receptor pathway protects against muscle weakness induced by dermatomyositis serum.

Journal: Annals of the rheumatic diseases

Published: November 18, 2025

Classification Criteria in Idiopathic Inflammatory Myopathies: Is It Time for an Update?

Classification Criteria in Idiopathic Inflammatory Myopathies: Is It Time for an Update?

Journal: Rheumatic diseases clinics of North America

Published: October 29, 2025

Sera from patients with dermatomyositis and antisynthetase syndrome mediate muscle weakness, impair mitochondrial respiration and induce local cytokine production in muscle tissue.

Sera from patients with dermatomyositis and antisynthetase syndrome mediate muscle weakness, impair mitochondrial respiration and induce local cytokine production in muscle tissue.

Journal: Journal of autoimmunity

Published: October 23, 2025

Showing 1-12 of 261

Last Updated: 09/26/2026